Protein aggregation in Huntington’s disease

Biochimie

Volumn 84, Issue 4, 2002, Pages 273-278

  Hoffner, Guylaine ^a   Djian, Philippe ^a  

^a UPR 2228CNRS   (France)

Author keywords

Aggregates; Huntington s disease; Inclusions; Polyglutamine

Indexed keywords

HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; PEPTIDE; PEPTIDE FRAGMENT; POLYGLUTAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; HUNTINGTIN;

ANIMAL; CELL DEATH; CELL INCLUSION; CELL NUCLEUS; CHEMISTRY; CYTOPLASM; HUMAN; HUNTINGTON CHOREA; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PROTEIN FOLDING; REVIEW; ULTRASTRUCTURE; BINDING KINETICS; BRAIN NERVE CELL; CATALYSIS; COVALENT BOND; DISEASE ASSOCIATION; HYDROGEN BOND; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN FUNCTION; TREATMENT PLANNING;

ANIMALS; CELL DEATH; CELL NUCLEUS; CYTOPLASM; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN FOLDING; TRANSGLUTAMINASES; ANIMAL; HUMAN;

EID: 0035997016     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(02)01398-6     Document Type: Article

References (44)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes
2. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
3. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
4. Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism
5. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
6. Incorporation of glutamine repeats makes protein oligomerize: Implication for neurodegenerative diseases
7. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
8. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
9. Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: Applying to quantification of protein components of the aggregates
10. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitement of normal polyglutamine proteins
11. Amyloid-like inclusions in Huntington’s disease
12. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its activity increases in Huntington’s disease brain nuclei
13. Transglutaminase activity in rat brain: Characterization, distribution, and changes with age
14. Differential expression of multiple transglutaminases in human brain
15. Neurodegenerative diseases and transglutaminase
16. Tissue transglutaminase is increased in Huntington’s disease brain
17. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system
18. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases
19. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and α-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length
20. Transglutaminase action imitates Huntington’s disease: Selective polymerization of huntingtin containing expanded polyglutamine
21. ε-(γ-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington’s disease
22. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates
23. Intranuclear neuronal inclusions in Huntington’s disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
24. Huntington’s disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein
25. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
26. Nuclear and neuropil aggregates in Huntington’s disease: Relationship to neuropathology
27. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
28. Identities of sequestred proteins in aggregates from cells with induced polyglutamine expression
29. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
30. The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription
31. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
32. Aberrant interactions of transcriptional repressor proteins with the Huntington’s disease gene product huntingtin
33. Effects of heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington’s disease
34. Impairment of the ubiquitin-proteasome system by protein aggregation
35. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease
36. A cellular model that recapitulates major pathogenic steps of Huntington’s disease
37. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
38. Mutant protein in Huntington disease is resistant to proteolysis in affected brain
39. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies
40. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with β-tubulin: Relevance to Huntington disease
41. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription
42. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation
43. Aggresomes: A cellular response to misfolded proteins
44. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1